Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryCRO

PUBLISHER: Grand View Research | PRODUCT CODE: 1772409

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1772409

Topical Drugs CDMO Market Size, Share & Trends Analysis Report By Formulation (Semi-solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products), By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Topical Drugs CDMO Market Growth & Trends:

The global topical drugs CDMO market size is expected to reach USD 14.22 billion by 2033, registering a CAGR of 7.5% from 2025 to 2033, according to a new report by Grand View Research, Inc. There is an increasing need for specialized topical drugs to address various skin-related and dermatological conditions. Healthcare providers and patients seek customized solutions, leading to a rise in demand for CDMOs with specialized expertise in topical drugs.

The market is fragmented, with several players having similar technological and processing capabilities. The development of innovative drug delivery technologies, such as microemulsions, nanotechnology, and transdermal patches, has extended the abilities of CDMOs to create more patient-friendly and effective topical drug products. Furthermore, a growing trend towards personalized medicine has significantly boosted demand for topical drug CDMOs, as they play a fundamental role in personalizing topical treatments to individual patient conditions and needs.

Collaborations between CDMOs and pharmaceutical companies have risen, with CDMOs contributing to the manufacturing and development of innovative and new topical drugs. Pharmaceutical firms significantly opt for outsourcing with an aim to focus on core competencies such as research, distribution, and marketing while entrusting manufacturing services to dedicated CDMOs. The increasing number of FDA approvals and product launches in topical medications significantly contributes to CDMOs specializing in topical drug manufacturing growth. For instance, in May 2022, Dermavant Sciences received the U.S. Food and Drug Administration (FDA) approval for its VTAMA (tapinarof) cream, 1%, for the topical management of plaque psoriasis in adults.

The COVID-19 pandemic negatively impacted the market. The pandemic has significantly disrupted the global supply chains, affecting the accessibility of manufacturing capabilities and raw materials. Several clinical studies, including those for topical medicine, were temporarily delayed or put on hold owing to safety concerns. This disturbed the testing and development of new topical drug treatments and formulations. However, by adopting strategic initiatives such as acquisition and partnerships with specialized drug providers, the industry regained its market shares by 2021.

Topical Drugs CDMO Market Report Highlights:

  • Based on formulation, the semi-solid formulations segment held the largest revenue share of 66.44% in 2024.The segment is driven by the growing demand for creams, gels, and ointments and the rise in clinical trials involving topical drugs. The cream sub-category, on the other hand, held the lion's share owing to increasing approval of topical creams for several medical conditions.
  • Based on the service, the contract manufacturing segment held the largest revenue share in 2024. The high shares of the segment are majorly due to the growing demand for outsourced manufacturing services, driven by the cost-effectiveness of outsourced manufacturing.
  • In terms of end-use, the biopharmaceutical companies segment is anticipated to witness highest CAGR during the forecast period owing to the rise in focus on R&D activities pertaining to the development of topical medication.
  • Asia Pacific is anticipated to register the significant CAGR over the forecast period. The region's substantial growth is primarily attributed to the cost-effective manufacturing of topical products due to lower labor and operational costs in several Asian economies.
Show more
Product Code: GVR-4-68040-150-0

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Formulation
    • 1.2.2. Service
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Topical Drugs CDMO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High demand for non-invasive treatment options to boost sales of topical drugs
      • 3.2.1.2. Growing pipeline of topical drugs
      • 3.2.1.3. Growing research and development investments
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Compliance with strict regulatory requirements
      • 3.2.2.2. Limited efficacy in certain conditions limits adoption of topical products
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. R&D Spending Analysis (2021-2024)
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. Topical Drugs CDMO Market: Formulation Estimates & Trend Analysis

  • 4.1. Topical Drugs CDMO Market, By Formulation: Segment Dashboard
  • 4.2. Topical Drugs CDMO Market, By Formulation: Movement Analysis
  • 4.3. Topical Drugs CDMO Market Estimates & Forecasts, By Formulation, 2021 - 2033 (USD Million)
  • 4.4. Semi-solid Formulations
    • 4.4.1. Semi-Solid Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Creams
      • 4.4.2.1. Creams Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Ointments
      • 4.4.3.1. Ointments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Gel
      • 4.4.4.1. Gel Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Liquid Formulations
    • 4.5.1. Liquid Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Solid Formulations
    • 4.6.1. Solid Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Transdermal Products
    • 4.7.1. Transdermal Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Topical Drugs CDMO Market: Indication by Service Estimates & Trend Analysis

  • 5.1. Topical Drugs CDMO Market, Indication by Service: Segment Dashboard
  • 5.2. Topical Drugs CDMO Market, Indication by Service: Movement Analysis
  • 5.3. Topical Drugs CDMO Market Estimates & Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
  • 5.4. Contract Development
    • 5.4.1. Contract Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Contract Manufacturing
    • 5.5.1. Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Topical Drugs CDMO Market: End Use Estimates & Trend Analysis

  • 6.1. Topical Drugs CDMO Market, By End Use: Segment Dashboard
  • 6.2. Topical Drugs CDMO Market, By End Use: Movement Analysis
  • 6.3. Topical Drugs CDMO Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 6.4. Pharmaceutical Companies
    • 6.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Biopharmaceutical Companies
    • 6.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Topical Drugs CDMO Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2033
  • 7.3. North America
    • 7.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Market Position Analysis, 2024 (Heat Map Analysis)
  • 8.3. Company Profiles
    • 8.3.1. Lubrizol Life Science
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Cambrex Corporation
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Contract Pharmaceuticals Limited
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Bora Pharmaceutical CDMO
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Ascendia Pharmaceuticals
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Pierre Fabre group
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Piramal Pharma Solutions
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. DPT Laboratories, LTD
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. MedPharm Ltd
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. PCI Pharma Services
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives

Chapter 9 Key Recommendations

Show more
Product Code: GVR-4-68040-150-0

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 Global Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 5 Global Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 6 Global Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 7 Global Topical Drugs CDMO Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million)
  • Table 8 North America Topical Drugs CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 9 North America Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 10 North America Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 11 North America Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 12 U.S. Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 13 U.S. Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 14 U.S. Topical Drugs CDMO Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 15 U.S. Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 16 Canada Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 17 Canada Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 18 Canada Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 19 Mexico Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 20 Mexico Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 21 Mexico Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 22 Europe Topical Drugs CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 23 Europe Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 24 Europe Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 25 Europe Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 26 UK Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 27 UK Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 28 UK Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 29 Germany Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 30 Germany Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 31 Germany Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 32 France Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 33 France Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 34 France Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 35 Italy Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 36 Italy Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 37 Italy Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 38 Spain Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 39 Spain Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 40 Spain Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 41 Denmark Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 42 Denmark Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 43 Denmark Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 44 Sweden Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 45 Sweden Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 46 Sweden Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 47 Norway Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 48 Norway Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 49 Norway Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Topical Drugs CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 52 Asia Pacific Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 53 Asia Pacific Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 54 Japan Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 55 Japan Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 56 Japan Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 57 China Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 58 China Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 59 China Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 60 India Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 61 India Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 62 India Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 63 Australia Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 64 Australia Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 65 Australia Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 66 Thailand Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 67 Thailand Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 68 Thailand Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 69 South Korea Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 70 South Korea Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 71 South Korea Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 72 Latin America Topical Drugs CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 73 Latin America Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 74 Latin America Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 75 Latin America Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 76 Brazil Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 77 Brazil Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 78 Brazil Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 79 Argentina Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 80 Argentina Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 81 Argentina Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Topical Drugs CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 84 Middle East & Africa Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 85 Middle East & Africa Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 86 South Africa Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 87 South Africa Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 88 South Africa Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 90 Saudi Arabia Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 91 Saudi Arabia Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 92 UAE Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 93 UAE Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 94 UAE Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Topical Drugs CDMO Market Estimates and Forecasts, by Formulation, 2021 - 2033 (USD Million)
  • Table 96 Kuwait Topical Drugs CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 97 Kuwait Topical Drugs CDMO Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Topical Drugs CDMO Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Topical Drugs CDMO Market: Formulation outlook and key takeaways
  • Fig. 20 Topical Drugs CDMO Market: Formulation movement analysis
  • Fig. 21 Semi-solid Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Creams Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Ointments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Gel Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Liquid Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Solid Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Transdermal Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Topical Drugs CDMO Market: Service outlook and key takeaways
  • Fig. 30 Topical Drugs CDMO Market: Service movement analysis
  • Fig. 31 Contract Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Topical Drugs CDMO Market: End Use outlook and key takeaways
  • Fig. 34 Topical Drugs CDMO Market: End Use movement analysis
  • Fig. 35 Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Regional Marketplace: Key Takeaways
  • Fig. 39 North America Topical Drugs CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 U.S. Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Canada Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Mexico Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Europe Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 UK Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Germany Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 France Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Italy Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Spain Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Denmark Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Sweden Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Norway Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Asia Pacific Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Japan Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 China Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 India Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Australia Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Thailand Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 South Korea Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Latin America Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Brazil Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Argentina Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 MEA Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Africa Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Saudi Arabia Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 UAE Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Kuwait Topical Drugs CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key company categorization
  • Fig. 91 Service heat map analysis
  • Fig. 92 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!